Omda AS
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides con… Read more
Omda AS (OMDA) - Net Assets
Latest net assets as of September 2025: Nkr33.40 Million NOK
Based on the latest financial reports, Omda AS (OMDA) has net assets worth Nkr33.40 Million NOK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr704.24 Million) and total liabilities (Nkr670.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr33.40 Million |
| % of Total Assets | 4.74% |
| Annual Growth Rate | -53.68% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 147.9 |
Omda AS - Net Assets Trend (2021–2024)
This chart illustrates how Omda AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Omda AS (2021–2024)
The table below shows the annual net assets of Omda AS from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr17.05 Million | -82.10% |
| 2023-12-31 | Nkr95.26 Million | +231.06% |
| 2022-12-31 | Nkr28.77 Million | -83.24% |
| 2021-12-31 | Nkr171.69 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Omda AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Nkr2.10 Million | 12.30% |
| Other Components | Nkr14.96 Million | 87.70% |
| Total Equity | Nkr17.05 Million | 100.00% |
Omda AS Competitors by Market Cap
The table below lists competitors of Omda AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
XL Holdings Bhd
KLSE:7121
|
$25.85 Million |
|
GOLDPAC GROUP LTD
F:G9D
|
$25.86 Million |
|
PT Indo Boga Sukses Tbk
JK:IBOS
|
$25.86 Million |
|
BG T&A Co
KQ:046310
|
$25.86 Million |
|
Superkrane Mitra Utama Tbk PT
JK:SKRN
|
$25.84 Million |
|
Evergreen Max Cash Capital Berhad
KLSE:0286
|
$25.82 Million |
|
Dae Hyun
KO:016090
|
$25.82 Million |
|
Marchex Inc
NASDAQ:MCHX
|
$25.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Omda AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 95,257,000 to 17,052,000, a change of -78,205,000 (-82.1%).
- Net loss of 66,727,000 reduced equity.
- Dividend payments of 9,741,000 reduced retained earnings.
- Other factors decreased equity by 1,737,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-66.73 Million | -391.31% |
| Dividends Paid | Nkr9.74 Million | -57.13% |
| Other Changes | Nkr-1.74 Million | -10.19% |
| Total Change | Nkr- | -82.10% |
Book Value vs Market Value Analysis
This analysis compares Omda AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 49.64x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 5.13x to 49.64x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | Nkr8.19 | Nkr42.00 | x |
| 2022-12-31 | Nkr1.37 | Nkr42.00 | x |
| 2023-12-31 | Nkr4.66 | Nkr42.00 | x |
| 2024-12-31 | Nkr0.85 | Nkr42.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Omda AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -391.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15.60%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 46.20x
- Recent ROE (-391.31%) is below the historical average (-195.45%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -50.42% | -26.29% | 0.38x | 4.98x | Nkr-103.73 Million |
| 2022 | -457.37% | -35.75% | 0.53x | 24.10x | Nkr-134.48 Million |
| 2023 | 117.28% | 27.02% | 0.54x | 8.08x | Nkr102.20 Million |
| 2024 | -391.31% | -15.60% | 0.54x | 46.20x | Nkr-68.43 Million |
Industry Comparison
This section compares Omda AS's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $16,774,273
- Average return on equity (ROE) among peers: -276.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Omda AS (OMDA) | Nkr33.40 Million | -50.42% | 20.09x | $25.84 Million |
| ContextVision AB (CONTX) | $43.84 Million | 8.44% | 0.17x | $7.93 Million |
| Induct AS (INDCT) | $1.53 Million | -876.60% | 11.09x | $7.38 Million |
| Nordhealth AS (NORDH) | $4.95 Million | 38.92% | 1.60x | $88.25 Million |